APH Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Minerva Neurosciences Inc NERV Q1 2026 Earnings Wider Loss Highlights Ongoing PreRevenue Development Stage CDLR Q1 2026 Earnings EPS Misses Estimates as Operating Costs Weigh on Results ATOS Q1 2026 Earnings EPS Surprise of 8223 Highlights Cost Management in ClinicalStage Biotech MED Q1 2026 Earnings EPS Surprises with Smaller Loss Than Expected SailPoint Q1 2026 Earnings Slight EPS Miss Positive Market Reaction